Tafluprost 50742-0339
Product NDC
50742-0339- Manufacturer
- Ingenus Pharmaceuticals, Llc
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- December 18, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA218002
Need to source Tafluprost? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tafluprost | .015 mg/mL |
Drug Class
Prostaglandin Analog [EPC]Increased Prostaglandin Activity [PE]Prostaglandin Analog [EPC]
Packaging Options(1)
6 POUCH in 1 CARTON (50742-339-30) / 5 VIAL, SINGLE-DOSE in 1 POUCH (50742-339-05) / .3 mL in 1 VIAL, SINGLE-DOSE